Asia Pramulia Tbk. vs Merck Tbk. — how do they compare? Asia Pramulia Tbk. trades at Rp143 (market cap 393.24B, 23.66M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 4.3× Asia Pramulia Tbk.'s market cap, and Asia Pramulia Tbk. is more actively traded (23.66M versus 22.8K). Which is the better fit depends on your goals.
| ASPR | MERK | |
|---|---|---|
Market Cap | 393.24B | 1.68T |
Volume | 23.66M | 22.8K |
Lot | 236.55K | 228 |
Turnover | 3.35B | 82.9M |
Average Price | 141.58 | 3,636.14 |
Value | 3.35B | 82.9M |
Indicative Equilibrium Price | 143 | 3,520 |
Indicative Equilibrium Volume | 7.69K | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Asia Pramulia Tbk (Entity) was established based on deed No. 193 dated July 29, 1991 from Noor Irawati, S.H., Notary in Surabaya.
Read more on ASPR →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →